Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with combined SOS1 and MEK Inhibition for Improved Immunotherapy Response.
Norgard RJ, Budhani P, O'Brien SA, Xia Y, Egan JN, Flynn B, Tagore JR, Seco J, Peet GW, Mikucka A, Wasti R, Chan LC, Hinkel M, Martinez-Morilla S, Pignatelli J, Trapani F, Corse E, Feng D, Kostyrko K, Hofmann MH, Liu K, Kashyap A.
Norgard RJ, et al. Among authors: feng d.
Cancer Res Commun. 2024 May 10. doi: 10.1158/2767-9764.CRC-24-0172. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 38727236
Free article.